Cite
Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis.
MLA
Wen, Wen, et al. “Clinical Outcomes of PD-1/PD-L1 Inhibitors in Patients with Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.” Journal of Cancer Research & Clinical Oncology, vol. 149, no. 3, Mar. 2023, pp. 969–78. EBSCOhost, https://doi.org/10.1007/s00432-022-04057-3.
APA
Wen, W., Zhang, Y., Zhang, H., & Chen, Y. (2023). Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Cancer Research & Clinical Oncology, 149(3), 969–978. https://doi.org/10.1007/s00432-022-04057-3
Chicago
Wen, Wen, Yong Zhang, Hua Zhang, and Yingshuang Chen. 2023. “Clinical Outcomes of PD-1/PD-L1 Inhibitors in Patients with Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.” Journal of Cancer Research & Clinical Oncology 149 (3): 969–78. doi:10.1007/s00432-022-04057-3.